CN Stock MarketDetailed Quotes

300765 CSPC Innovation Pharmaceutical

Watchlist
  • 24.90
  • +0.87+3.62%
Market Closed Jul 12 15:00 CST
34.97BMarket Cap49.60P/E (TTM)

CSPC Innovation Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CSPC Innovation Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

524.07M

-27.08%
EPS(YoY)

0.07

-77.00%
Analyst Rating

Strong Buy

Jul 14, 2024

CSPC Innovation Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.264B--
--2024/FY-- / 3.062B--
--2023/FY2.502B / 2.708B--
--2022/FY2.626B / 1.958B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.264B--
--2024/FY-- / 3.062B--
--2023/FY2.502B / 2.708B--
--2022/FY2.626B / 1.958B--
--------

Unlock Free Earnings Estimates

CSPC Innovation Pharmaceutical Earnings Reports

  • New Novus: First quarter report 2024

    Apr 22 12:00 ET

  • New Novus: Annual Report 2023

    Mar 14 12:00 ET

  • New Novus: 2023 Annual Report Summary

    Mar 14 12:00 ET

  • Novi Novi: Report for the third quarter of 2023

    Oct 24, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 14, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg